Ibandronate sodium and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is found among people who take Ibandronate sodium, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Ibandronate sodium and have Fainting. It is created by eHealthMe based on reports of 2,870 people who have side effects when taking Ibandronate sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

2,870 people reported to have side effects when taking Ibandronate sodium.
Among them, 12 people (0.42%) have Fainting.

What is Ibandronate sodium?

Ibandronate sodium has active ingredients of ibandronate sodium. It is often used in osteoporosis post-menopausal. eHealthMe is studying from 2,903 Ibandronate sodium users for its effectiveness, alternative drugs and more.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 3,697 drugs and 3,385 conditions by eHealthMe.

Number of Ibandronate sodium and Fainting reports submitted per year:

Could Ibandronate sodium cause Fainting?

Time on Ibandronate sodium when people have Fainting *:

Gender of people who have Fainting when taking Ibandronate sodium *:

female: 80 %
male: 20 %

Age of people who have Fainting when taking Ibandronate sodium *:

Common drugs people take besides Ibandronate sodium *:

Common side effects people have besides Fainting *:

Dizziness: 6 people, 50.00%
Weakness: 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%
Pain: 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Chest Pain: 3 people, 25.00%
Muscle Aches (muscle pain): 2 people, 16.67%
Cough: 2 people, 16.67%
Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 2 people, 16.67%
Joint Pain: 2 people, 16.67%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 1 person, 8.33%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 8.33%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ibandronate sodium and have Fainting?

Check whether Fainting is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Ibandronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fainting treatments and more:

Fainting (118,546 reports)

COVID vaccines that are related to Fainting:

Common drugs associated with Fainting:

All the drugs that are associated with Fainting:

Fainting (3,697 drugs)

Common conditions associated with Fainting:

High blood pressure: 9,615 reports
Primary pulmonary hypertension: 5,065 reports
Depression: 3,616 reports
Multiple sclerosis: 3,399 reports
Rheumatoid arthritis: 3,257 reports
Pain: 3,113 reports
Multiple myeloma: 2,618 reports

All the conditions that are associated with Fainting:

Fainting (3,385 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibandronate sodium (the active ingredients of Ibandronate sodium) and Ibandronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.